Inactive Instrument

News Obagi Medical Products, Inc.

Equities

US67423R1086

End-of-day quote Nasdaq Other stock markets
- ^USD	-

2013	CONMED Corporation : Exclusive - Activist investor Voce pushes ConMed to sell	RE
2013	Obagi Medical Products, Inc. : Valeant sweetens bid for Obagi Medical	RE

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

CONMED Corporation : Exclusive - Activist investor Voce pushes ConMed to sell	13-11-04	RE
Obagi Medical Products, Inc. : Valeant Pharmaceuticals International, Inc. Announces Receipt of Approval From the Antimonopoly Committee of Ukraine for its Previously Announced Acquisition of Obagi Medical Products, Inc.	13-04-24	PR
Obagi Medical Products, Inc. : Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance In The United States For Its Previously Announced Acquisition Of Obagi Medical Products, Inc.	13-04-22	PR
Obagi Medical Products, Inc. : Valeant sweetens bid for Obagi Medical	13-04-03	RE
Obagi Medical Products, Inc. : and Valeant Pharmaceuticals, Inc. Agree on an Increased Offer Price of $24.00 per Share in Cash	13-04-03	BU
Obagi Medical Products, Inc. : Valeant Pharmaceuticals And Obagi Medical Products Agree On An Increased Offer Price Of $24.00 Per Share In Cash	13-04-03	PR
Obagi Medical Products, Inc. : Board of Directors of Obagi Medical Products, Inc. Receives Unsolicited Acquisition Proposal from Merz Pharma	13-04-02	BU
Valeant Pharmaceuticals Intl Inc : Obagi Medical gets higher offer from Merz Pharma	13-04-02	RE
Obagi Medical Products, Inc. : Merz Pharma Group Makes Superior Proposal to Acquire Obagi Medical Products	13-04-02	PR
Obagi Medical Products, Inc. : Law Office of Brodsky & Smith, LLC Announces Investigation of Obagi Medical Products, Inc.	13-03-22	PR
Obagi Medical Products, Inc. : Valeant to buy Obagi Medical for about $344 million	13-03-20	RE
Obagi Medical Products, Inc. : Valeant Pharmaceuticals International, Inc. Agrees to Acquire Obagi Medical Products, Inc. For $19.75 per Share in Cash	13-03-20	BU
Obagi Medical Products, Inc. : Valeant Pharmaceuticals International, Inc. Agrees to Acquire Obagi Medical Products, Inc. for $19.75 Per Share in Cash	13-03-20	PR
Obagi Medical Products, Inc. : Obagi Medical Products Reports Fourth Quarter and Year-End 2012 Financial Results	13-03-14	BU
Obagi Medical Products, Inc. : Obagi Medical Products to Report Fourth Quarter and Year End 2012 Financial Results and Host a Conference Call on March 14	13-02-21	BU
Obagi Medical Products, Inc. : Obagi Medical Products and Suneva Medical Partner to Offer ReGenica® Facial Rejuvenation Complex	13-01-30	BU
Obagi Medical Products, Inc. : Obagi Medical Confirms Receipt of Directors Nomination Notice from Voce Capital	12-12-10	BU
Obagi Medical Products, Inc. : Obagi Medical Products to Present at The Canaccord Genuity's Medical Technology and Diagnostics Forum Conference	12-11-28	BU
Obagi Medical Products, Inc. : Obagi Medical Products to Present at The 24th Annual Piper Jaffray Healthcare Conference	12-11-21	BU
Obagi Medical Products, Inc. : Obagi Medical Products Introduces Hydrate	12-11-14	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Obagi Medical Products, Inc.

Equities

US67423R1086

Summary

Filters